This is despite our analysis of the correlation between SND1 and cancer types represented in The Cancer Genome Atlas (TCGA) database indicating that SND1 is not elevated in kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP)—cancer types that sunitinib is commonly used to treat (Supplemental Figure 9). The gene discussed is SND1; the disease is cancer.